𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamivudine treatment of chronic hepatitis B: evaluation of drug-resistance by the INNO-LiPA HBV DR

✍ Scribed by R. Romeo; P. Lampertico; G. Zadra; M. Colombo


Book ID
119527284
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
132 KB
Volume
34
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Characteristics of lamivudine-resistant
✍ Norio Horiike; Tran Nhu Duong; Kojiro Michitaka; Kouji Joko; Yoichi Hiasa; Ichir πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 2 views

## Abstract Lamivudine therapy often causes breakthrough of hepatitis B virus (HBV) DNA and breakthrough hepatitis. The aim of this study was to determine the viral factors that relate to HBV‐DNA breakthrough with and without breakthrough hepatitis. Among 82 patients with chronic hepatitis B (CHB)